Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients

By Colak T.   Karakayali H.   Yagmurdur M.C.   Moray G.  

Transplantation Proceedings, Vol. 34, Iss. 6, 2002-09 ,pp. : 2081-2082

Elsevier

Access to resources Recommend Favorite

Improvement of cardiovascular risk factors in heart transplant recipients after conversion from cyclosporine to tacrolimus: a role of the TGF- system

By van Riemsdijk I.C.   Baan C.C.   Balk A.H.M.M.   Vantrimpont P.M.A.J.   Maat L.P.W.M.   Weimar W.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1864-1865

Elsevier

Access to resources Recommend Favorite

Conversion From Neoral (Cyclosporine) to Tacrolimus of Kidney Transplant Recipients for Gingival Hyperplasia or Hypertrichosis

By Busque S.   Demers P.   St-Louis G.   Boily J.-G.   Tousignant J.   Lemieux F.   Smeesters C.   Corman J.   Daloze P.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1247-1248

Elsevier

Access to resources Recommend Favorite

Conversion from cyclosporine to tacrolimus for refractory acute rejection in pediatric kidney transplant recipients: a single-center experience

By Ferraresso M.   Ghio L.   Edefonti A.   Garavaglia R.   Pozzoli E.   Berardinelli L.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3590-3591

Elsevier

Access to resources Recommend Favorite

Conversion to tacrolimus to ameliorate cyclosporine toxicity in kidney recipients

By Burrows L.   Knight R.   Genyk Y.   Schwartz B.   Moran V.   Anand R.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2030-2032

Elsevier

Access to resources Recommend Favorite